⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37624 | 1.00 | — | — | |
| SCHEMBL2267145 | 1.00 | — | — | |
| SCHEMBL6271848 | 0.86 | — | — | |
| SCHEMBL7433871 | 0.84 | CRBN (0.34) | — | |
| SCHEMBL7428318 | 0.82 | KMT2A (0.34) | — | |
| SCHEMBL7433746 | 0.82 | KMT2A (0.34) | — | |
| SCHEMBL7430825 | 0.82 | KMT2A (0.34) | — | |
| SCHEMBL21693765 | 0.78 | — | — | |
| SCHEMBL10820878 | 0.78 | — | — | |
| SCHEMBL6442975 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2868 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024123562-A2 | PEPTIDE INHIBITORS OF BETA-LACTAMASE | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2024-06-13 | — | — | WO | claimed |
| CN-114761561-B | Recombinant C-reactive protein | 东洋纺株式会社 | 2024-04-30 | — | — | CN | claimed |
| CN-111315878-B | Modified L-asparaginase | 爵士制药爱尔兰有限公司 | 2024-04-26 | — | — | CN | claimed |
| WO-2024086381-A2 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | ENDEVICA BIO, INC. (US) | 2024-04-25 | — | — | WO | claimed |
| EP-3642340-B1 | MODIFIED L-ASPARAGINASE | JAZZ PHARMACEUTICALS IRELAND LTD (IE) | 2024-03-20 | — | — | EP | claimed |
| CN-112930195-B | Anti-human Fn14 antibodies | 安斯泰来制药株式会社 | 2024-03-19 | — | — | CN | claimed |
| WO-2023240155-A1 | METHODS FOR TREATING DRY EYE DISEASE | THE SCHEPENS EYE RESEARCH INSTITUTE, INC. (US) | 2023-12-14 | — | — | WO | claimed |
| CN-117222672-A | anti-CLDN 4-anti-CD 137 bispecific antibodies | 安斯泰来制药株式会社 | 2023-12-12 | — | — | CN | claimed |
| CN-117120476-A | Antibodies specific for structurally disordered sequences | XL-普洛坦公司 | 2023-11-24 | — | — | CN | claimed |
| US-11813237-B2 | Creatine, its derivatives, compositions and methods of use thereof | YU RUEY J (US) | 2023-11-14 | — | — | US | claimed |
| EP-0010830-A2 | Dehydropeptides | Research Corporation (US) | 1980-05-14 | — | — | EP | claimed |
| WO-1980000351-A1 | ANALYTICAL FLUOROGENIC SUBSTRATES FOR PROTEOLYTIC ENZYMES | AMERICAN HOSPITAL SUPPLY CORP (US) | 1980-03-06 | — | — | WO | claimed |
| US-4186198-A | OLIGOPEPTIDES | NYEGAARD & CO. A/S (NO) | 1980-01-29 | — | — | US | claimed |
| US-4164571-A | Medicament which antagonizes the action of gastrin and related polypeptides | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1979-08-14 | — | — | US | claimed |
| EP-0002039-A1 | Phosphonous acid derivatives, processes for their preparation and their use in combating microorganisms | CIBA-GEIGY AG (CH) | 1979-05-30 | — | — | EP | claimed |
| EP-0001335-A1 | A peptide, processes for its preparation and compositions containing the same | NYEGAARD & CO. A/S (NO) | 1979-04-04 | — | — | EP | claimed |
| EP-0001174-A1 | A peptide and the salts thereof, processes for their preparation and compositions containing them | NYEGAARD & CO. A/S (NO) | 1979-03-21 | — | — | EP | claimed |
| US-4012367-A | Anti-ulcer polypeptides containing L-aspartic acid and intermediates thereto | G. D. SEARLE & CO. (US) | 1977-03-15 | — | — | US | claimed |
| US-3971736-A | HEXA- AND HEPTA-PEPTIDES, ANTIINFLAMMATORY, ANTIULCER, ANTIARTHRITIC | MERCK & CO., INC. (US) | 1976-07-27 | — | — | US | claimed |
| US-3934008-A | PEPTIDES, HYPOCALCAEMIC | CIBA-GEIGY CORPORATION (US) | 1976-01-20 | — | — | US | claimed |